Nigerian boxer Cynthia Temitayo Ogunsemilore’s Olympic dreams have been shattered after she was suspended for violating anti-doping regulations. The International Testing Agency (ITA) announced on Saturday that a sample collected from Ogunsemilore on Thursday, a day before the Paris Olympics opening ceremony, tested positive for furosemide, a banned diuretic and masking agent.
Furosemide is prohibited by the World Anti-Doping Agency (WADA) as it can be used to reduce weight or mask the presence of other performance-enhancing substances. The 22-year-old Ogunsemilore, who was set to make her Olympic debut in the under 60 kg category on Monday, has been provisionally suspended until the resolution of the matter.
The ITA stated that Ogunsemilore has been informed of the case and has the right to challenge her suspension at the Court of Arbitration for Sport. She can also request an analysis of the B sample.
Ogunsemilore’s suspension marks the third doping case at the Paris Olympics. Iraqi judoka Sajjad Sehen tested positive for anabolic steroids, while Dominican volleyball player Lisvel Eve Mejia also tested positive for furosemide.
The ITA’s swift action in detecting and suspending athletes for doping violations sends a strong message that the use of performance-enhancing substances will not be tolerated at the Olympics. It also highlights the importance of maintaining a level playing field and protecting the integrity of the Games.
Ogunsemilore’s suspension is a major setback for the Nigerian boxing team and a reminder that the fight against doping in sports remains an ongoing battle. It is crucial for athletes to adhere to anti-doping regulations and prioritize fair play and ethical competition.
